Glycyron: glycyrrhizin with glycine and methionine — where it helps and who should not take it
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120

Glycyron: glycyrrhizin with glycine and methionine — where it helps and who should not take it

Glycyron is a Japanese medicine made of glycyrrhizic acid from licorice, glycine and methionine: its benefit in alopecia areata, eczema, urticaria, psoriasis, vitiligo and liver disease in human studies, how to take it and who should see a doctor first.

Glycyron: glycyrrhizin with glycine and methionine — where it helps and who should not take it
Glycyron is a Japanese tablet made of glycyrrhizic acid from licorice, glycine and methionine: the tablets have been produced since 1954, the current formula since 1991. Together with standard treatment, compound glycyrrhizin of the same formula taken by mouth more often gave complete hair regrowth in alopecia areata and marked improvement in eczema, compound glycyrrhizin helped in urticaria, psoriasis and vitiligo, and in a Japanese double-blind study Glycyron improved liver test results in chronic hepatitis. In plain words: what is inside, how it helps, how to take it and who should see a doctor first.

Key points

Glycyron (グリチロン配合錠, Minophagen, Japan) is a tablet with 25 mg of glycyrrhizic acid from licorice root, 25 mg of glycine and 25 mg of DL-methionine (package insert of Japan’s PMDA agency, rev. 05.2026); the table shows where the benefit of this formula has been shown in humans: apart from the chronic hepatitis row, these are studies of Chinese “compound glycyrrhizin” and other licorice preparations.

ConditionHow it helpsWhat human studies showed
Alopecia areatawith usual treatment, hair regrows completely more often23 studies, 2,219 people: complete regrowth 1.6 times more often (Li M Ann Med 2025. PMID 40265259)
Chronic eczemawith a steroid ointment — marked improvement and fewer relapsesdouble-blind with placebo, 199 adults: EASI down by at least 75% in 47.9% vs 21.2%, relapses 3.19% vs 12.12% (Xu W Evid Based Complement Alternat Med 2020. PMID 32308712)
Chronic urticariawith an antihistamine — complete cure more often, fewer relapses24 studies, 2,649 people: cure 1.54 times more often, relapses three times less often (data on 446 people) (Chen S J Dermatolog Treat 2024. PMID 38166511)
Psoriasis vulgariswith usual treatment, psoriasis severity falls markedly more often11 studies: PASI 60 30% more often (Yu JJ Curr Med Res Opin 2017. PMID 27786567)
Vitiligowith usual treatment — a better overall result17 studies, 1,492 people: overall efficacy 1.54 times higher (Li M Expert Rev Clin Pharmacol 2023. PMID 37218470)
Chronic hepatitisimproves liver test resultsJapanese double-blind with placebo, 224 people: clear improvement in 22.3% vs 11.8% (PMDA package insert 2026)
Liver diseaselicorice preparations lower liver enzymes15 studies, 1,367 people: ALT lower by an average of 15.6 U/L, AST by 7.4 U/L (Giangrandi I Phytother Res 2024. PMID 39079711)

Composition and benefit of each ingredient

Glycyrrhizic acid, 25 mg. A substance from licorice root. Among licorice preparations, the liver enzymes ALT and AST were lowered particularly by purified glycyrrhizic acid (Giangrandi I Phytother Res 2024. PMID 39079711).

Glycine, 25 mg, and DL-methionine, 25 mg. According to the label, they are added to reduce the sodium and fluid retention caused by glycyrrhizin (studied only in animals; PMDA package insert 2026).

The same formula in China. There it is produced as “compound glycyrrhizin”: 25 mg of glycyrrhizin, 25 mg of glycine and 25 mg of methionine in a tablet or capsule (Li M Ann Med 2025. PMID 40265259). Most studies were done with it.

Where it is used. In Japan, Glycyron has been produced since 1954, and the current formula was approved in 1991. It is approved for eczema and dermatitis, papular urticaria in children (strophulus), alopecia areata, stomatitis and for improving liver test results in chronic liver disease; it is also sold in China, Mongolia, Uzbekistan and Armenia (PMDA package insert 2026).

How it helps

Alopecia areata. In 23 studies (2,219 people), compound glycyrrhizin added to usual treatment gave complete hair regrowth 1.6 times more often and improved the score on the SALT hair-loss severity scale (Li M Ann Med 2025. PMID 40265259). In 11 studies (1,189 people), together with minoxidil the SALT score fell by a further 10 points compared with minoxidil alone (Guo C J Dermatolog Treat 2024. PMID 39230160). For the main treatment, see the guide to alopecia areata.

Eczema. At 6 centers in China, 199 adults with chronic eczema received capsules 3 times a day or placebo for 28 days, and all of them used the steroid ointment mometasone 0.1% once a day. With the capsules, the Eczema Area and Severity Index (EASI) fell by at least 75% in 47.9% versus 21.2%, and relapses occurred in 3.19% versus 12.12%. There was no significant difference in side effects (Xu W Evid Based Complement Alternat Med 2020. PMID 32308712).

Urticaria. In 24 studies (2,649 people) with chronic urticaria, compound glycyrrhizin together with a second-generation antihistamine gave complete cure 1.54 times more often and relapses three times less often (data on 446 people) than an antihistamine alone (Chen S J Dermatolog Treat 2024. PMID 38166511).

Psoriasis and vitiligo. In psoriasis vulgaris (plaque psoriasis), in 11 studies, compound glycyrrhizin added to usual treatment gave a reduction in the Psoriasis Area and Severity Index (PASI) of at least 60% 30% more often, with the same rate of side effects (Yu JJ Curr Med Res Opin 2017. PMID 27786567). In vitiligo, in 17 studies (1,492 people), compound glycyrrhizin added to usual treatment raised overall efficacy 1.54 times (Li M Expert Rev Clin Pharmacol 2023. PMID 37218470).

Liver. In a Japanese double-blind study, 224 people with chronic hepatitis at 19 centers took 9 Glycyron tablets a day or placebo for 12 weeks. A clear improvement in liver test results occurred in 22.3% versus 11.8% (PMDA package insert 2026).

How to take it

According to the Japanese label, adults are prescribed 2–3 tablets 3 times a day after meals, children 1 tablet 3 times a day (PMDA package insert 2026).

The adult dose is 150–225 mg of glycyrrhizic acid a day, while for food the EU scientific committee considers regular intake of up to 100 mg a day from all sources, including licorice confectionery, safe for most people (EU Scientific Committee on Food 2003). The limit is set for food, not for a medicine taken under a doctor’s supervision, but it explains why blood pressure and potassium are monitored on Glycyron.

Japanese Glycyron (100 tablets) is available in the shop — ordered on request via chat, taken as prescribed by a doctor.

Who should see a doctor first

  • Contraindicated according to the label: end-stage liver cirrhosis with raised blood ammonia (a methionine metabolite may interfere with its clearance), aldosteronism, myopathy (muscle disease) and low potassium (PMDA package insert 2026).
  • The main risk is pseudoaldosteronism, and its frequency is unknown. Licorice interferes with the kidney’s conversion of cortisol into inactive cortisone, and cortisol starts retaining sodium like the hormone aldosterone (Stewart PM Lancet 1987. PMID 2889032). Swelling, rising blood pressure, weight gain, less urine and weakness are a reason to see a doctor right away; potassium and blood pressure are monitored during treatment.
  • Rhabdomyolysis (muscle breakdown), its frequency also unknown: with weakness, muscle pain or cramps, see a doctor right away; if creatine kinase (CK) and myoglobin rise, the drug is stopped.
  • Do not combine it with other products that contain licorice: the glycyrrhizin adds up. On the risks of licorice in supplements, see the article on adaptogens.
  • Use caution with diuretics (loop and thiazide), as potassium falls further, and with the antibiotic moxifloxacin: with low potassium, dangerous heart rhythm disturbances with QT prolongation on the ECG are possible.
  • In older people, low potassium is more common.
  • In pregnancy, only if the doctor decides that the benefit outweighs the risk; during breastfeeding, the decision is made individually.

Side effects in studies. In alopecia, swelling was more common, and low potassium occurred in 1 of 253 people taking it whose potassium was checked (Li M Ann Med 2025. PMID 40265259). In eczema, the most common was leg swelling (Xu W Evid Based Complement Alternat Med 2020. PMID 32308712).

Bottom line

Compound glycyrrhizin of the same formula taken by mouth together with standard treatment improved outcomes in alopecia areata and eczema, compound glycyrrhizin together with standard treatment did so in urticaria, psoriasis and vitiligo, and in a Japanese double-blind study Glycyron improved liver test results in chronic hepatitis. It is taken as prescribed by a doctor, with blood pressure and potassium monitoring. You can discuss whether it suits you at a consultation.

Source: Glycyron: glycyrrhizin with glycine and methionine — where it helps and who should not take it — universum.earth. Dr. Pereligyn.

Come back
Request a call back